|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
102.77(B) |
Last
Volume: |
8,713,116 |
Avg
Vol: |
8,469,733 |
52
Week Range: |
$48.64 - $73.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
96,581 |
377,614 |
901,711 |
1,862,313 |
Total Sell Value |
$6,534,949 |
$22,111,166 |
$49,794,655 |
$91,194,728 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
10 |
20 |
37 |
70 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-03-20 |
4 |
AS |
$18.00 |
$630,000 |
D/D |
(35,000) |
87,981 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-03-20 |
4 |
OE |
$12.52 |
$438,200 |
D/D |
35,000 |
122,981 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-03-20 |
4 |
AS |
$18.00 |
$324,900 |
D/D |
(18,050) |
25,600 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-03-20 |
4 |
OE |
$8.30 |
$223,541 |
D/D |
18,050 |
43,650 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-03-19 |
4 |
AS |
$17.77 |
$196,964 |
D/D |
(11,085) |
87,981 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-03-16 |
4 |
AS |
$17.18 |
$515,634 |
D/D |
(30,022) |
99,066 |
|
- |
|
Sorenson John Bradley |
SVP, Manuf & Sup Chn |
|
2015-03-13 |
4 |
AS |
$16.84 |
$64,497 |
D/D |
(3,830) |
11,476 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-03-09 |
4 |
AS |
$16.54 |
$42,359 |
D/D |
(2,561) |
25,600 |
|
- |
|
Prange Karen |
SVP&Pres, Uro & Womens Health |
|
2015-03-03 |
4 |
AS |
$16.79 |
$41,838 |
D/D |
(2,492) |
17,430 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-03-03 |
4 |
AS |
$16.79 |
$214,359 |
D/D |
(12,768) |
129,088 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2015-03-03 |
4 |
AS |
$16.79 |
$150,814 |
D/D |
(8,983) |
28,161 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2015-02-28 |
4 |
D |
$16.90 |
$44,937 |
D/D |
(2,659) |
90,754 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,911 |
93,413 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2015-02-28 |
4 |
D |
$16.90 |
$35,794 |
D/D |
(2,118) |
43,584 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,514 |
45,702 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2015-02-28 |
4 |
D |
$16.90 |
$76,625 |
D/D |
(4,534) |
180,783 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,624 |
185,317 |
|
- |
|
Bose Supratim |
EVP & President, Asia-Pacific |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,766 |
116,395 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-02-28 |
4 |
D |
$16.90 |
$109,799 |
D/D |
(6,497) |
141,856 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,791 |
148,353 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & President, CRM |
|
2015-02-28 |
4 |
D |
$16.90 |
$78,044 |
D/D |
(4,618) |
128,254 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & President, CRM |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,580 |
132,872 |
|
- |
|
Thepaut Eric Francis Yves |
SVP & Pres, Europe |
|
2015-02-28 |
4 |
D |
$16.90 |
$31,552 |
D/D |
(1,867) |
98,323 |
|
- |
|
Thepaut Eric Francis Yves |
SVP & Pres, Europe |
|
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,485 |
100,190 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2015-02-28 |
4 |
D |
$16.90 |
$30,217 |
D/D |
(1,788) |
133,646 |
|
- |
|
2007 Records found
|
|
Page 1 of 81 |
|
|